Navigation Links
Synaptics Reports Record Results for First Quarter of Fiscal 2009
Date:10/23/2008

t, net 24,203 22,459

Goodwill 1,927 1,927

Non-current investments 35,341 37,946

Other assets 4,183 3,669

Total assets $333,733 $306,361

Liabilities and stockholders' equity

Current liabilities:

Accounts payable $29,799 $27,784

Accrued compensation 6,464 6,510

Income taxes payable 8,415 7,095

Other accrued liabilities 8,502 9,120

Total current liabilities 53,180 50,509

Convertible senior subordinated notes 125,000 125,000

Other liabilities 18,200 17,075

Commitments and contingencies

Stockholders' equity:

Preferred stock;

$.001 par value; 10,000,000

shares authorized;

no shares issued and

outstanding - -

Common stock;

$.001 par value; 60,000,000

shares authorized; 42,835,461

and 42,500,535 shares issued,

and 33,747,361 and 33,412,435

shares outstanding, respectively 43 43

Additional paid in capital 233,049 222,543

Less: 9,088,100 and 9,088,100

treasury shares, respectively,

at cost (237,387) (237,387)

Retained earnings 144,854 130,895

Accumulated other comprehensive

loss (3,206) (2,317)

Total stockholders' equity 137,353 113,777

Total liabili
'/>"/>

SOURCE Synaptics Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology news :

1. Synaptics to Report First Quarter Results on October 23
2. Synaptics SecurePad(TM) Selected as CES Innovations 2008 Design and Engineering Award Honoree
3. GEN reports on novel tools for deciphering biological networks
4. Genetic Engineering & Biotechnology News reports on growing role of molecular diagnostics
5. LSUHSC research reports new method to protect brain cells from diseases like Alzheimers
6. Communication Intelligence Corporation Reports Second Quarter 2008 Financial Results
7. BIO-key(R) Reports Profitability on Strong Revenue Growth for Second Quarter 2008
8. BIO-key(R) Reports Profitability on Strong Revenue Growth for Second Quarter 2008
9. Limiting fructose may boost weight loss, UT Southwestern researcher reports
10. Genetic Engineering & Biotechnology News reports on novel hit-to-lead drug discovery
11. BIO-key(R) Reports First Quarter 2008 Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)...n it comes to investment in energy efficient techn...ences Research Council (EPSRC) Chief Executive Dav...and engineering research has already brought us fu...but more investment is needed to develop the capab...ur carbon emission targets by 2020 and limit the i...
(Date:12/2/2009)...results strengthen the evidence that people who sm...increased risk for developing colorectal cancer, e...This provides one more reason not to smoke, or to ...ael J. Thun, M.D., M.S., vice president emeritus, ...ican Cancer Society. "Colorectal cancer should be ...
(Date:12/2/2009)... a cancer-free status did not prompt people partic...) lung-cancer screening program to pick up their c...ished in Cancer Epidemiology, Biomarkers & Preven...ancer Research. The December issue contains a spec...gate widespread concern in the lung screening comm...
Breaking Biology News(10 mins):Research is vital to a cleaner, greener, low carbon future 2Cigarette smoking increases colorectal cancer risk 2Repeat negative CT scan for lung cancer does not encourage ex-smokers to resume the habit 2Statins May Worsen Fatigue in Heart Failure Patients 60606 1Statins May Worsen Fatigue in Heart Failure Patients 60606 2Statins May Worsen Fatigue in Heart Failure Patients 60606 3Sun or shade 3A Pecan leaves photosynthetic light response evaluated 10611 1Sun or shade 3A Pecan leaves photosynthetic light response evaluated 10611 2A Breast Cancer Test That Saves Lives 60601 1A Breast Cancer Test That Saves Lives 60601 2A Breast Cancer Test That Saves Lives 60601 3
...ransform the dead bone of a transplanted skeletal ...g mice. The advance, which uses gene therapy to st...as living bone, is a promising development for the... who suffer with fragile and failing bone grafts. ...ppear in the March 1 issue of Nature Medicine. , ...
...ve been,viewed as the real movers and shakers in g...a messenger that shuttles information between the,...Biomedical Research,and Massachusetts Institute of...es called microRNAs regulate thousands of human ge...oding regions. In other words,a class of molecule...
...oomberg School of Public Health are exploring ways...s using genetically modified adenoviruses, a commo... vaccines have long been proven to be safe and eff...constructing a replicating live recombinant adenov...rovide longer-lasting disease protection, which wo...
Other Biology News:Gene therapy converts dead bone graft to new, living tissue 2Gene therapy converts dead bone graft to new, living tissue 3Gene therapy converts dead bone graft to new, living tissue 4NYU researchers simulate molecular biological clock 2Live Recombinant Adenovirus Vaccine Technique Explored 2
(Date:12/3/2009)... , HOPKINTON, Mass., Dec. 3 /PRNewswire-FirstC... ), a leading provider of tools and services for d...troduced Living Image 4.0 software for IVIS® ...ves the more than 800 Caliper IVIS systems current...ge 4.0 features advanced spectral unmixing tools t...
(Date:12/2/2009)... , COLUMBIA, Md., Dec. 2 /PRNewswire-FirstCall... ) announced today that it intends to release the ... on December 16, 2009, at approximately 4:00 p.m. ... p.m. ET Martek will conduct a conference call to ...ted parties may listen to the call live via webcas...
(Date:12/2/2009)... , NEW YORK, Dec. 2 Report...port is available in its catalogue: ,, Neurost...tp://www.reportlinker.com/p0164232/Neurostimulatio...orld neurostimulation market stands enthused by th...ant rise in age-related diseases such as, Parkinso...
(Date:12/2/2009)... , NEW YORK, Dec. 2 Report...port is available in its catalogue: ,, Drug Di...rends & Opportunities ,, http://www.repor...-A-Global-Update-of-Market-Trends--Opportunities.h...nd ongoing element of every pharmaceutical company...
Breaking Biology Technology:Caliper Life Sciences Launches Living Image(R) 4.0 Software 2Martek to Announce Fourth Quarter and Fiscal Year 2009 Results 2Reportlinker Adds Neurostimulation - A Global Market Perspective 2Reportlinker Adds Neurostimulation - A Global Market Perspective 3Reportlinker Adds Neurostimulation - A Global Market Perspective 4Reportlinker Adds Neurostimulation - A Global Market Perspective 5Reportlinker Adds Neurostimulation - A Global Market Perspective 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 8Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 9
...an. 28 /PRNewswire-FirstCall/ - Quest PharmaTech I...t it has signed a,collaborative research agreement... a combination therapy for the treatment of lung c...mpany,s lead oncology product,SL052, with various ...photodynamic therapy (PDT) can augment the therape...
...N.J., Jan 28 Phytomedics Inc., a clinical,stage b...mponent /,multi-targeted drug products, announced ...althcare Conference in Boston, Massachusetts on We... topics of the presentation will be an overview of...ents, including Phase III development,activities r...
...x(TM) Platform Accurately Mimics a Human Capillary...national,provider of microfluidic systems in the e...y its worldwide launch of its VenaFlux(TM),Platfor...h throughput,microfluidic cell- based assay system...othelial- cell cultured microchannels, producing I...
Other Biology Technology:Quest PharmaTech and BC Cancer Agency to Develop Immuno Photodynamic Therapies for Lung Cancer 2Quest PharmaTech and BC Cancer Agency to Develop Immuno Photodynamic Therapies for Lung Cancer 3Cellix Ltd. Launches the First Semi-Automated, High Throughput Cell-Adhesion Assay Platform 2
...ser Capture Microdissection (LCM) is the method of...ritas Microdissection is the only instrument to of...d flexibility., UV Laser Cutting provides ...n-soft tissues and capturing large numbers of cell...
Hybridizer (220 V) from Dako
...e NanoChip 400 System is an automated multiplexing... for performing SNP detection, pathogen sequence d...le samples with multiple targets can be applied to...anoChip cartridge, which may be reused until all t...
Bio-Plex Manager Version 3.0 to 4.0 Workstation Software Upgrade Kit from Bio-Rad
Biology Products: